Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4.

Jean-Daniel LalauFarshad KajbafYoussef BennisAnne-Sophie Hurtel-LemaireFrans BelpaireMarc E De Broe

Published in: Diabetes care (2018)

Provided that the dose is adjusted for renal function, metformin treatment appears to be safe and still pharmacologically efficacious in moderate-to-severe CKD.

Keyphrases

chronic kidney disease
end stage renal disease
early onset
high intensity
combination therapy
replacement therapy
drug induced